Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma

1 Jan 2006

Abstract excerpt

Multiple myeloma is a genetically heterogenous disease with a wide variety of characterized genetic aberrations. Until recently, the impact of these aberrations on patient outcome was not known. However, in the last 5-10 years, several genetic markers have been linked to patient outcome. One of the strongest predictors of outcome identified to date is t(4;14)(p16;q32). Although this translocation is tightly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Peptidase Inhibition and Analysis
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17107900
DOI: 10.1080/10428190600822128

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myelomaPMID 17107900Read ↗

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesionsSemantic proximity Read ↗

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?Semantic proximity Read ↗

Many Multiple Myelomas: Making More of the Molecular MayhemSemantic proximity Read ↗

Molecular aspects of multiple myelomaSemantic proximity Read ↗

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Semantic proximity Read ↗

Clinical and biologic implications of recurrent genomic aberrations in myelomaSemantic proximity Read ↗

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocationSemantic proximity Read ↗

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapySemantic proximity Read ↗

Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 casesSemantic proximity Read ↗

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myelomaSemantic proximity Read ↗

The biology of multiple myeloma.Semantic proximity Read ↗

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.